A specialized medical nutrition production enterprise is set to emerge within the Nakhabino Park industrial park in Krasnogorsk, near Moscow. This is a project of the Biosynthesis Technologies company, 65% owned by Skopinfarm. Investments in it are estimated at 1.3 billion rubles.
The facility is dedicated to producing parenteral and enteral nutrition, which are essential for the comprehensive treatment of critically ill patients who are unable to consume food independently. The ministry referred to the project as “import substitution.” Moreover, the company plans to provide food not only to Russia, but also to Kazakhstan, Armenia, Kyrgyzstan, and Belarus.
A plot of 2.8 hectares was allocated to the company under the “Land for 1 ruble” program. There are plans to construct a manufacturing and storage facility complete with administrative and support areas, along with a control and analysis laboratory. The plant is expected to begin operations in 2026.
